# A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

> **NCT05951192** · PHASE4 · COMPLETED · sponsor: **USRC Kidney Research** · enrollment: 161 (actual)

## Conditions studied

- Anemia
- Renal Insufficiency, Chronic
- Renal Anemia

## Interventions

- **DRUG:** Daprodustat

## Key facts

- **NCT ID:** NCT05951192
- **Lead sponsor:** USRC Kidney Research
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-01
- **Primary completion:** 2024-02-14
- **Final completion:** 2024-02-14
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2024-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05951192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05951192, "A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05951192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*